title: Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors.
abstract: To define some of the mechanisms underlying dextran sulfate (DXS)-induced hypotension, we investigated the effects of either the plasma kallikrein inhibitor des-Pro2-[Arg15] aprotinin (BAY x 4620) or the specific bradykinin B2-receptor antagonist Hoe-140 on the hypotensive response to DXS. In the first study, anesthetized miniature pigs were given DXS alone, DXS plus BAY x 4620 in various doses, or saline. As expected, DXS alone produced a profound but transient systemic arterial hypotension with a concomitant reduction in kininogen. Circulating kinin levels, complement fragment des-Arg-C3a, and fibrin monomer were all increased. Treatment with BAY x 4620 produced a dose-dependent attenuation of these effects with complete blockade of the hypotension as well as the observed biochemical changes at the highest dose (360 mg). In a second study, two groups of pigs were given either DXS alone or DXS plus Hoe-140. DXS-induced hypotension was completely blocked by Hoe-140 pretreatment; however, kininogen was again depleted. We conclude, therefore, that DXS-induced hypotension is produced by activation of plasma kallikrein that results in the production of bradykinin and that liberation of bradykinin and its action on B2 receptors in the vasculature are both necessary and sufficient to produce the observed effects on circulatory pressure.
authors.affiliation: Department of Surgery, Ludwig-Maximilians University, Klinikum Innenstadt, Munich, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Siebeck
authors.forename: J C
authors.initials: JC
authors.lastname: Cheronis
authors.forename: E
authors.initials: E
authors.lastname: Fink
authors.forename: J
authors.initials: J
authors.lastname: Kohl
authors.forename: B
authors.initials: B
authors.lastname: Spies
authors.forename: M
authors.initials: M
authors.lastname: Spannagl
authors.forename: M
authors.initials: M
authors.lastname: Jochum
authors.forename: H
authors.initials: H
authors.lastname: Fritz
mesh_terms: D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001158:Arteries / Q000503:physiopathology*; D001794:Blood Pressure / Q000187:drug effects; D003167:Complement Activation; D016264:Dextran Sulfate / Q000494:pharmacology; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D007022:Hypotension / Q000139:chemically induced* / Q000503:physiopathology*; D007704:Kininogens / Q000097:blood; D007705:Kinins / Q000097:blood; D011651:Pulmonary Artery / Q000503:physiopathology; D018002:Receptors, Bradykinin / Q000145:classification / Q000502:physiology*; D011994:Recombinant Proteins / Q000494:pharmacology; D013552:Swine; D013556:Swine, Miniature
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D007704:Kininogens; D007705:Kinins; D018002:Receptors, Bradykinin; D011994:Recombinant Proteins; C092617:aprotinin, desprolyl(2)-arginyl(15)-; C011468:fibrinmonomer; D016264:Dextran Sulfate; D007611:Aprotinin